Diagnostics, Science & Technology

Day: Thursday   |   Time: 13:45 - 15:15

Session Coordinators: 
Julie Staves & Yvonne Scott

Speakers: 

How immunogenic is RhD positive transfusions to RhD negative patients
Prof. Mark Yazer, University of Pittsburgh

Monoclonal antibodies and the problems with provision of safe red cells 
Dr Mark Williams, NHSBT Filton

Oral Presentations:

RHCE*Ce329C: a novel RHCE allele associated with a weakened C antigen expression and genetically linked to RHD*DVII allele
Cedric Vrignaud

cffDNA RhD typing – learning from 12 months experience
Julie Staves

Intended Audience: 
BMS, Medical Staff

Learning Objectives: TBC

Brief Description: 
This session will look at issues associated with red cell antibodies and the impact of them on the provision of red cells. The sensitisation with anti-D in RHD negative patients is an important issue as it increases the amount of O RhD negative red cells we use as a service. The use of monoclonal antibodies as a treatment for haematological malignancies is increasing, the problems associated to their use and how we provide safe red cell transfusions. 

Session Tags: 

This site uses cookies that enable us to make improvements, provide relevant content, and for analytics purposes. For more details, see our Cookie Policy. By clicking Accept, you consent to our use of cookies.